The impact of ageing on the health and wellbeing of people with thalidomide embryopathy: a comparison of the health impact with the general population.

Individuals with TE report significantly more health and well-being concerns than the general population of a similar age. Long-term monitoring is needed to ensure that support and rehabilitation services can meet their evolving needs.